236 related articles for article (PubMed ID: 19320649)
1. Should macroprolactin be measured in all hyperprolactinaemic sera?
McKenna TJ
Clin Endocrinol (Oxf); 2009 Oct; 71(4):466-9. PubMed ID: 19320649
[TBL] [Abstract][Full Text] [Related]
2. Macroprolactinaemia: prevalence and aetiologies in a large group of hospital workers.
Hattori N; Ishihara T; Saiki Y
Clin Endocrinol (Oxf); 2009 Nov; 71(5):702-8. PubMed ID: 19486017
[TBL] [Abstract][Full Text] [Related]
3. Determination of prolactin: the macroprolactin problem.
Fahie-Wilson M; Smith TP
Best Pract Res Clin Endocrinol Metab; 2013 Oct; 27(5):725-42. PubMed ID: 24094642
[TBL] [Abstract][Full Text] [Related]
4. Characterization of macroprolactin and assessment of markers of autoimmunity in macroprolactinaemic patients.
Kavanagh-Wright L; Smith TP; Gibney J; McKenna TJ
Clin Endocrinol (Oxf); 2009 Apr; 70(4):599-605. PubMed ID: 18771565
[TBL] [Abstract][Full Text] [Related]
5. Patients with macroprolactinaemia: clinical and radiological features.
Donadio F; Barbieri A; Angioni R; Mantovani G; Beck-Peccoz P; Spada A; Lania AG
Eur J Clin Invest; 2007 Jul; 37(7):552-7. PubMed ID: 17576206
[TBL] [Abstract][Full Text] [Related]
6. Macroprolactinaemia in patients with hyperprolactinaemia: composition of macroprolactin and stability during long-term follow-up.
Hattori N; Ishihara T; Saiki Y; Shimatsu A
Clin Endocrinol (Oxf); 2010 Dec; 73(6):792-7. PubMed ID: 20874771
[TBL] [Abstract][Full Text] [Related]
7. Importance of screening for macroprolactin in all hyperprolactinaemic sera.
Jamaluddin FA; Sthaneshwar P; Hussein Z; Othman N; Chan SP
Malays J Pathol; 2013 Jun; 35(1):59-63. PubMed ID: 23817395
[TBL] [Abstract][Full Text] [Related]
8. Clinical and radiological features of patients with macroprolactinaemia.
Strachan MW; Teoh WL; Don-Wauchope AC; Seth J; Stoddart M; Beckett GJ
Clin Endocrinol (Oxf); 2003 Sep; 59(3):339-46. PubMed ID: 12919157
[TBL] [Abstract][Full Text] [Related]
9. Hyperprolactinaemia does not always mean 'hyperprolactinaemia'!
Gezer A; Atasü T; Hekim C; Stenman UH; Hekim N
Eur J Obstet Gynecol Reprod Biol; 2005 Feb; 118(2):206-8. PubMed ID: 15653204
[TBL] [Abstract][Full Text] [Related]
10. Macroprolactin; high molecular mass forms of circulating prolactin.
Fahie-Wilson MN; John R; Ellis AR
Ann Clin Biochem; 2005 May; 42(Pt 3):175-92. PubMed ID: 15949152
[TBL] [Abstract][Full Text] [Related]
11. [Macroprolactinemia in the differential diagnosis of hyperprolactinemia].
Toldy E; Löcsei Z; Szabolcs I; Kneffel P; Góth M; Szöke D; Kovács LG
Orv Hetil; 2003 Oct; 144(43):2121-7. PubMed ID: 14661444
[TBL] [Abstract][Full Text] [Related]
12. Interference by macroprolactin in assays for prolactin: will the
Fahie-Wilson MN; Cobbaert CM; Horvath AR; Smith TP
Clin Chem Lab Med; 2022 Aug; 60(9):1350-1355. PubMed ID: 35704648
[TBL] [Abstract][Full Text] [Related]
13. Screening for macroprolactinaemia and pituitary imaging studies.
Hauache OM; Rocha AJ; Maia AC; Maciel RM; Vieira JG
Clin Endocrinol (Oxf); 2002 Sep; 57(3):327-31. PubMed ID: 12201824
[TBL] [Abstract][Full Text] [Related]
14. Prolactin and macroprolactin: a case report of hyperprolactinaemia highlighting the interpretation of discrepant results.
Ismail AA; Walker PL; Fahie-Wilson MN; Jassam N; Barth JH
Ann Clin Biochem; 2003 May; 40(Pt 3):298-300. PubMed ID: 12803849
[TBL] [Abstract][Full Text] [Related]
15. Frequent misdiagnosis and mismanagement of hyperprolactinemic patients before the introduction of macroprolactin screening: application of a new strict laboratory definition of macroprolactinemia.
Suliman AM; Smith TP; Gibney J; McKenna TJ
Clin Chem; 2003 Sep; 49(9):1504-9. PubMed ID: 12928232
[TBL] [Abstract][Full Text] [Related]
16. Macroprolactin(s): composition and reactivity in immunoassays and laboratory interpretation of results of an unusual patient serum.
Ellis AR; Fahie-Wilson M; Axcell M; Sands K; Hill RP
Ann Clin Biochem; 2006 Jan; 43(Pt 1):57-62. PubMed ID: 16390610
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of hyperprolactinaemia with the use of the intervals for prolactin after macroforms separation.
Beda-Maluga K; Pisarek H; Komorowski J; Swietoslawski J; Fuss-Chmielewska J; Winczyk K
J Physiol Pharmacol; 2014 Jun; 65(3):359-64. PubMed ID: 24930507
[TBL] [Abstract][Full Text] [Related]
18. The detection of macroprolactin by precipitation and ultrafiltration methods.
Beda-Maluga K; Pisarek H; Komorowski J; Pawlikowski M; Świętosławski J; Winczyk K
Endokrynol Pol; 2011; 62(6):529-36. PubMed ID: 22144220
[TBL] [Abstract][Full Text] [Related]
19. Application of new homologous in vitro bioassays for human lactogens to assess the actual bioactivity of human prolactin isoforms in hyperprolactinaemic patients.
Leaños-Miranda A; Cárdenas-Mondragón G; Rivera-Leaños R; Ulloa-Aguirre A; Goffin V
Clin Endocrinol (Oxf); 2006 Aug; 65(2):146-53. PubMed ID: 16886952
[TBL] [Abstract][Full Text] [Related]
20. Macroprolactinaemia: validation and application of the polyethylene glycol precipitation test and clinical characterization of the condition.
Olukoga AO; Kane JW
Clin Endocrinol (Oxf); 1999 Jul; 51(1):119-26. PubMed ID: 10468974
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]